| Overview |
| bsm-62978r-pe-cy5-100ul |
| FATP4 Recombinant Monoclonal Antibody, PE-Cy5 Conjugated |
| WB, FCM |
| Human, Mouse, Rat |
| Specifications |
| PE-Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human FATP 4 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10999 |
| Q6P1M0 |
| Cell membrane |
| ACSVL4; FATP4; Fatty acid transport protein 4; IPS; S27A4; Solute carrier family 27 member4. |
| Mediates the levels of long-chain fatty acids (LCFA) in the cell by facilitating their transport across cell membranes.Appears to be the principal fatty acid transporter in small intestinal enterocytes.Also functions as an acyl-CoA ligase catalyzing the ATP-dependent formation of fatty acyl-CoA using LCFA and very-long-chain fatty acids (VLCFA) as substrates, which prevents fatty acid efflux from cells and might drive more fatty acid uptake. |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
Powered by Bioz